Use of Artificial Intelligence
U-Prevent’s research has resulted in smart algorithms determining an individual’s risk of contracting cardiovascular disease. It provides an insight into the effects medication use and/or lifestyle has on the risk for the individual patient.
What challenge does it solve?
The interactive calculation tool is user-friendly and helps to prevent, encourage and facilitate joint decision-making. The effect of the appropriate management of medication or lifestyle adaptation is expressed as the decrease in risk over a 10-year period, and the increase in healthy life expectancy.
Leveraging NL AIC to drive implementation
The NL AIC supports the introduction of U-Prevent for use in clinical practice. It enables, on the one hand, a dialogue concerning structural funding with respect to valuable AI innovations, which are being jointly explored by U-Prevent, healthcare institutes, healthcare insurers and governmental organisations. On the other hand, the NL AIC offers support with validating the methods used for linking U-Prevent to digital dossiers, so that patient data can be used safely when used by the calculation tool or stored in the cloud.
U-Prevent: “The team greatly appreciates that the NL AIC stimulates the use of AI in the field of health and care. The cooperation is characterised by enthusiasm and commitment from all parties involved”.
Made possible by:
U-Prevent was developed in collaboration with UMC Utrecht, Harvard Medical School, Erasmus MC, LUMC, AMC, ORTEC, Amphia Ziekenhuis Breda, the Netherlands Professional Association for Cardiologists, including European Society for Cardiology ESC.
Interested? Visit the website of U-Prevent.com for more information.